PROT# CA-ALT-801-02-09: Phase Ib/II Study of ALT-801 with Cisplatin in Patients with Metastatic Melanoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date8/20/10 → 2/4/13

    Funding

    • Altor BioScience Corporation (CA-ALT-801-02-09//2R44CA097550-05A1)
    • National Cancer Institute (CA-ALT-801-02-09//2R44CA097550-05A1)
    View all
    View less